Wayne DeVeydt's Sale of Surgery Partners, Inc. Common Stock

Wayne DeVeydt, a former director of Surgery Partners, Inc., has filed a Form 144 to report the sale of common stock. The filing indicates that DeVeydt plans to sell 25,076 shares of common stock acquired through equity compensation. The sale is expected to occur on or around October 15, 2025, with an aggregate market value of approximately $526,899.48. Additionally, the filing discloses that DeVeydt has sold a significant amount of common stock in the past three months, totaling over 800,000 shares with gross proceeds exceeding $12 million. These sales were executed through UBS Financial Services Inc., acting as the broker. The filing highlights DeVeydt's ongoing divestment of his holdings in Surgery Partners, Inc.